Cannabis and Pregnancy: Risks and Evidence

Plain-language summary

Using cannabis during pregnancy is associated with measurable risks to the baby — most consistently, lower birth weight Strong evidence. Other potential risks (preterm birth, stillbirth, later behavioral or cognitive effects in childhood) show up in some studies but not others, and the research is tangled with other risk factors like tobacco use and socioeconomic stress Disputed.

No trimester, no dose, and no route of administration (smoking, vaping, edibles, CBD-only products) has been shown to be safe in pregnancy No data. Major medical organizations — the American College of Obstetricians and Gynecologists (ACOG), the U.S. Surgeon General, and the World Health Organization — all recommend against cannabis use during pregnancy and breastfeeding ^[1][2][3].

This article is not medical advice. If you are pregnant, trying to conceive, or breastfeeding, talk to a clinician. Honest disclosure to your OB or midwife will get you better care, not legal trouble in most jurisdictions — but the legal landscape varies, so know your local rules.

What the evidence shows (probable risks)

Lower birth weight. This is the most replicated finding. A 2016 meta-analysis in BMJ Open pooling 24 studies found prenatal cannabis exposure was associated with reduced birth weight and increased likelihood of NICU admission ^[4]. A 2020 meta-analysis in JAMA Network Open reached similar conclusions, with cannabis-exposed infants weighing roughly 100g less on average even after adjusting for tobacco co-use Strong evidence^[5].

Preterm birth. Multiple cohort studies and meta-analyses report a modest increase in preterm delivery risk among people who use cannabis during pregnancy Weak / limited. Effect sizes are smaller and less consistent than the birth-weight signal, and confounding by tobacco is hard to fully eliminate ^[4][5].

Stillbirth. A large NIH-funded study (the Stillbirth Collaborative Research Network) found an association between cannabinoid exposure and stillbirth, but it could not separate cannabis from tobacco use Weak / limited^[6].

Biological plausibility. THC crosses the placenta and reaches the fetus ^[7]. The endocannabinoid system plays a role in fetal brain development, placental function, and implantation, which provides a plausible mechanism for harm even if the epidemiological signal is modest Strong evidence^[8].

What might be risky (weaker evidence)

Neurodevelopmental and behavioral effects in childhood. Long-running cohort studies (the Ottawa Prenatal Prospective Study and the Maternal Health Practices and Child Development Study) reported associations between prenatal cannabis exposure and later attention, impulse control, and executive function differences Weak / limited^[9]. More recent analyses from the ABCD study have found small associations with psychopathology symptoms in children Weak / limited^[10]. These studies cannot prove causation — families that use cannabis during pregnancy also differ in many other ways that affect child development.

Pregnancy loss and congenital anomalies. Evidence is inconsistent. Some studies find small increases in specific anomalies (e.g., gastroschisis); others find no effect Disputed.

CBD-only products. Often marketed as 'safe' alternatives. There are essentially no human pregnancy safety data for CBD. Animal studies have shown reproductive toxicity at high doses, and the FDA has explicitly warned against CBD use during pregnancy and breastfeeding No data^[11].

What doesn't work (and what's being marketed anyway)

Cannabis for morning sickness (hyperemesis gravidarum). A widely cited 2018 study found that many U.S. dispensary employees, when called by a pregnant 'mystery shopper,' recommended cannabis products for nausea Strong evidence^[12]. There are no randomized controlled trials demonstrating that cannabis safely or effectively treats pregnancy-related nausea No data.

There is, however, a documented complication called cannabinoid hyperemesis syndrome (CHS) — chronic cannabis users can develop severe cyclic vomiting that mimics or worsens hyperemesis gravidarum Strong evidence^[13]. Some pregnant patients hospitalized for intractable vomiting turn out to have CHS, and their symptoms resolve only after stopping cannabis.

Cannabis as a 'natural' alternative to prescription medications. Standard antiemetics used in pregnancy (doxylamine-pyridoxine, ondansetron with appropriate counseling, metoclopramide) have far more safety data than cannabis. 'Natural' is a marketing word, not a safety claim.

Comparison with standard treatments

For the conditions people most commonly cite as reasons to use cannabis during pregnancy:

• Nausea/vomiting: First-line is vitamin B6 (pyridoxine) ± doxylamine (Diclegis/Diclectin), with decades of safety data Strong evidence^[14]. Ondansetron, metoclopramide, and promethazine are second-line options your OB can discuss.
• Anxiety and insomnia: Cognitive behavioral therapy, sleep hygiene, and — when needed — pregnancy-considered SSRIs have more safety data than cannabis Strong evidence.
• Pain: Acetaminophen remains the standard; physical therapy and non-drug approaches are first-line for chronic pain. Cannabis has no controlled-trial evidence supporting use in pregnant patients No data.

None of these standard treatments are risk-free, but the comparison isn't 'cannabis vs. a risky drug.' It's 'cannabis (poorly studied, signal of fetal harm) vs. medications with decades of pregnancy data.'

What we don't know

• Dose-response. We don't have good data on whether occasional use carries the same risk as daily use, though daily/heavy use shows stronger signals in cohort studies.
• Route of administration. Edibles, vapes, and smoking likely differ in pharmacokinetics and combustion exposure, but pregnancy studies rarely distinguish them.
• High-THC modern cannabis. Most longitudinal studies were started when average THC content was much lower than today's flower and concentrates. The current risk profile may be larger than older studies suggest.
• CBD specifically. Essentially no human pregnancy data.
• Causation vs. correlation. Disentangling cannabis from tobacco, alcohol, polysubstance use, poverty, and stress is genuinely hard, and the honest answer is that residual confounding remains in most studies Disputed.

Risks summary and bottom line

Established or likely risks: lower birth weight, possibly higher rates of NICU admission and preterm birth.

Possible but uncertain risks: stillbirth, neurodevelopmental and behavioral effects in childhood, congenital anomalies, cannabinoid hyperemesis syndrome misdiagnosed as morning sickness.

Unknown: safe dose, safe trimester, safety of CBD-only products, long-term effects of high-potency modern cannabis exposure.

Given that (a) THC reaches the fetus, (b) the endocannabinoid system is involved in fetal brain development, (c) the most consistent epidemiological signal points to fetal growth restriction, and (d) there are alternatives with better safety data for the conditions people use cannabis to treat — the consensus medical recommendation is to abstain during pregnancy and breastfeeding ^[1][2][3].

This article is not medical advice. It's a summary of evidence as of 2024. Your situation is specific to you. If you're using cannabis and are pregnant or might be, talk to a clinician. Stopping abruptly is generally safe; not stopping carries risks you can't undo later.

Sources

How this page was made

Related

• Cannabis and Breastfeeding — What we actually know about THC, CBD, and lactation — and the wide gap between confident a...